EaseMyTrip Founder Reaffirms Security Accusation Against MakeMyTrip

EaseMyTrip founder, Nishant Pitti, is escalating his allegations against MakeMyTrip, accusing the travel giant of compromising national security through its association with a Chinese investor. Pitti claims that MakeMyTrip’s connection to Ctrip (now Trip.com Group), a Chinese entity, poses a significant risk to India’s data security and sovereignty. He argues that sensitive user data, including travel patterns and personal information, could be vulnerable to access and potential misuse by the Chinese government.

Pitti specifically highlights Ctrip’s considerable stake in MakeMyTrip and its influence on the company’s operations. He suggests this influence extends to data storage and processing practices, potentially routing Indian user data through servers located outside of India, making it subject to Chinese law.

The founder contends that this situation warrants serious scrutiny from Indian authorities, urging them to investigate the potential implications for national security and data privacy. He emphasizes the importance of safeguarding citizens’ personal information and preventing any foreign entity from gaining undue access to sensitive data related to Indian travelers.

This renewed focus on the MakeMyTrip-Ctrip connection reignites a long-standing debate surrounding data security concerns associated with foreign investments in Indian companies, especially those involving nations with strained geopolitical relations. Pitti asserts that his concerns are not motivated by business rivalry but by a genuine commitment to national security and the protection of Indian citizens’ interests. He encourages the government to establish stricter regulations and oversight mechanisms to ensure that foreign investments do not compromise India’s strategic interests or the privacy of its citizens. This development adds another layer of complexity to the competitive landscape of the online travel industry in India, potentially influencing consumer trust and regulatory scrutiny.

Read the Complete Article.